...
search icon
amrx-img

Amneal Pharmaceuticals, Inc. Class A Common Stock, Common Stock

AMRX

NSQ

$7.16

-$0.03

(-0.42%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.38B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.09M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.17
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.29 L
$9.47 H
$7.16

About Amneal Pharmaceuticals, Inc. Class A Common Stock, Common Stock

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAMRXSectorS&P500
1-Week Return-5.79%-1.91%-1.87%
1-Month Return-1.92%-3.82%8.93%
3-Month Return-13.73%-11.56%-2.39%
6-Month Return-14.56%-10.21%-2.41%
1-Year Return11.18%-9.91%10.88%
3-Year Return113.73%-0.28%46.93%
5-Year Return44.06%31.29%94.89%
10-Year Return-84.19%75.9%177.5%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.99B2.09B2.21B2.39B2.79B[{"date":"2020-12-31","value":71.32,"profit":true},{"date":"2021-12-31","value":74.94,"profit":true},{"date":"2022-12-31","value":79.18,"profit":true},{"date":"2023-12-31","value":85.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue1.36B1.31B1.43B1.53B1.77B[{"date":"2020-12-31","value":76.92,"profit":true},{"date":"2021-12-31","value":73.85,"profit":true},{"date":"2022-12-31","value":80.5,"profit":true},{"date":"2023-12-31","value":86.25,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit628.39M783.95M791.46M820.57M1.02B[{"date":"2020-12-31","value":61.58,"profit":true},{"date":"2021-12-31","value":76.82,"profit":true},{"date":"2022-12-31","value":77.56,"profit":true},{"date":"2023-12-31","value":80.41,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin31.54%37.44%35.78%34.28%36.52%[{"date":"2020-12-31","value":84.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.54,"profit":true},{"date":"2023-12-31","value":91.55,"profit":true},{"date":"2024-12-31","value":97.54,"profit":true}]
Operating Expenses517.31M616.26M595.79M659.50M667.15M[{"date":"2020-12-31","value":77.54,"profit":true},{"date":"2021-12-31","value":92.37,"profit":true},{"date":"2022-12-31","value":89.3,"profit":true},{"date":"2023-12-31","value":98.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income91.16M152.72M(94.93M)204.37M249.33M[{"date":"2020-12-31","value":36.56,"profit":true},{"date":"2021-12-31","value":61.25,"profit":true},{"date":"2022-12-31","value":-38.07,"profit":false},{"date":"2023-12-31","value":81.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(272.93M)(257.68M)(311.87M)(496.08M)(562.93M)[{"date":"2020-12-31","value":-27293300000,"profit":false},{"date":"2021-12-31","value":-25767500000,"profit":false},{"date":"2022-12-31","value":-31186700000,"profit":false},{"date":"2023-12-31","value":-49607800000,"profit":false},{"date":"2024-12-31","value":-56293400000,"profit":false}]
Pre-Tax Income(35.78M)31.37M(248.13M)(40.27M)(55.01M)[{"date":"2020-12-31","value":-114.07,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-791.07,"profit":false},{"date":"2023-12-31","value":-128.39,"profit":false},{"date":"2024-12-31","value":-175.39,"profit":false}]
Income Taxes(104.36M)11.20M6.66M8.45M18.86M[{"date":"2020-12-31","value":-553.24,"profit":false},{"date":"2021-12-31","value":59.35,"profit":true},{"date":"2022-12-31","value":35.32,"profit":true},{"date":"2023-12-31","value":44.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes68.58M20.17M(254.79M)(48.72M)(73.88M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":29.41,"profit":true},{"date":"2022-12-31","value":-371.53,"profit":false},{"date":"2023-12-31","value":-71.05,"profit":false},{"date":"2024-12-31","value":-107.73,"profit":false}]
Income From Continuous Operations68.58M20.17M(254.79M)(48.72M)(73.88M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":29.41,"profit":true},{"date":"2022-12-31","value":-371.53,"profit":false},{"date":"2023-12-31","value":-71.05,"profit":false},{"date":"2024-12-31","value":-107.73,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income68.58M10.62M(129.99M)(83.99M)(116.89M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":15.49,"profit":true},{"date":"2022-12-31","value":-189.54,"profit":false},{"date":"2023-12-31","value":-122.48,"profit":false},{"date":"2024-12-31","value":-170.44,"profit":false}]
EPS (Diluted)0.630.840.680.640.58[{"date":"2020-12-31","value":75,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.95,"profit":true},{"date":"2023-12-31","value":76.19,"profit":true},{"date":"2024-12-31","value":69.05,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AMRX
Cash Ratio 0.06
Current Ratio 1.40
Quick Ratio 0.84

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AMRX
ROA (LTM) 6.67%
ROE (LTM) -881.26%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AMRX
Debt Ratio Lower is generally better. Negative is bad. 1.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.30

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AMRX
Trailing PE NM
Forward PE 6.30
P/S (TTM) 1.18
P/B 86.10
Price/FCF NM
EV/R 1.69
EV/Ebitda 8.70

FAQs

What is Amneal Pharmaceuticals, Inc. Class A Common Stock share price today?

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) share price today is $7.16

Can Indians buy Amneal Pharmaceuticals, Inc. Class A Common Stock shares?

Yes, Indians can buy shares of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) on Vested. To buy Amneal Pharmaceuticals, Inc. Class A Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AMRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Amneal Pharmaceuticals, Inc. Class A Common Stock be purchased?

Yes, you can purchase fractional shares of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) via the Vested app. You can start investing in Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) with a minimum investment of $1.

How to invest in Amneal Pharmaceuticals, Inc. Class A Common Stock shares from India?

You can invest in shares of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in AMRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Amneal Pharmaceuticals, Inc. Class A Common Stock shares
What is Amneal Pharmaceuticals, Inc. Class A Common Stock 52-week high and low stock price?

The 52-week high price of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is $9.47. The 52-week low price of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is $6.29.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 86.10

What is the Market Cap of Amneal Pharmaceuticals, Inc. Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is $2.38B

What is Amneal Pharmaceuticals, Inc. Class A Common Stock’s stock symbol?

The stock symbol (or ticker) of Amneal Pharmaceuticals, Inc. Class A Common Stock is AMRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top